Adial Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 2.55 M | $561.98 K | 100.00% | 11.52% |
| CITADEL ADVISORS LLC | 02/17/2026 | 219.62 K | $48.32 K | 52.74% | 0.99% |
| VANGUARD GROUP INC | 01/29/2026 | 156.02 K | $34.33 K | 0.00% | 0.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 155.75 K | $34.26 K | -5.11% | 0.70% |
| JANE STREET GROUP, LLC | 02/12/2026 | 121.84 K | $26.81 K | 887.29% | 0.55% |
| NORTHERN TRUST CORP | 02/17/2026 | 65.98 K | $14.52 K | 100.00% | 0.30% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 63.83 K | $14.00 K | 100.00% | 0.29% |
| XTX TOPCO LTD | 02/17/2026 | 52.10 K | $11.46 K | 100.00% | 0.24% |
| MANCHESTER CAPITAL MANAGEMENT LLC | 02/11/2026 | 48.10 K | $10.58 K | 0.00% | 0.22% |
| BLACKROCK, INC. | 02/12/2026 | 27.77 K | $6.11 K | 0.00% | 0.13% |
| STONEX GROUP INC. | 02/12/2026 | 19.45 K | $4.28 K | 100.00% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 17.07 K | $3.76 K | 32.96% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 12.09 K | $2.66 K | 100.00% | 0.05% |
| PRIVATE MANAGEMENT GROUP INC | 02/12/2026 | 10.00 K | $2.20 K | 0.00% | 0.05% |
| UBS GROUP AG | 01/29/2026 | 9.17 K | $2.02 K | -51.13% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.34 K | $295 | -2.12% | 0.01% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 1.16 K | $255 | -17.05% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 205 | $45 | 12.64% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 160 | $35 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/09/2026 | 99 | $22 | 100.00% | 0.00% |
| ABOUND WEALTH MANAGEMENT | 01/12/2026 | 27 | $6 | 0.00% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 9 | $2 | 0.00% | 0.00% |
| HRT FINANCIAL LP | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
Adial Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 31 institutional investors and hedge funds held shares of Adial Pharmaceuticals Inc. The most heavily invested institutionals were:
VANGUARD FIDUCIARY TRUST CO: 5,879
Manchester Capital Management LLC: 1,923
UBS Group AG: 542
SBI Securities Co., Ltd.: 47
Caitong International Asset Management Co., Ltd: 15
WELLS FARGO & COMPANY/MN: 6
15.95% of Adial Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.45 M shares in the last 24 months. This purchase volume represents approximately $5.93 M in transactions.